SARS-CoV-2 Seroprevalence and Cross-Variant Antibody Neutralization in Cats, United Kingdom

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Tyson, Grace B. ; Jones, Sarah ; Logan, Nicola ; McDonald, Michael ; Marshall, Leigh ; Murcia, Pablo R. ; Willett, Brian J. ; Weir, William ; Hosie, Margaret J.
• Description:
  Anthropogenic transmission of SARS-CoV-2 to pet cats highlights the importance of monitoring felids for exposure to circulating variants. We tested cats in the United Kingdom for SARS-CoV-2 antibodies; seroprevalence peaked during September 2021-February 2022. The variant-specific response in cats trailed circulating variants in humans, indicating multiple human-to-cat transmissions over a prolonged period.
• Subjects:
  Animals Anthropozoonoses Antibodies, Viral Cats COVID-19 Dispatch ELISA Humans Humoral Immunity One Health Pseudotype Virus Neutralization Assay Respiratory Infections SARS-CoV-2 SARS-CoV-2 Seroprevalence And Cross-Variant Antibody Neutralization In Cats, United Kingdom Seroepidemiologic Studies Seroprevalence Severe Acute Respiratory Syndrome Coronavirus 2 United Kingdom Viruses Zoonoses

  More +
• Source:
  Emerg Infect Dis. 2023; 29(6):1223-1227
• Pubmed ID:
  37141617
• Pubmed Central ID:
  PMC10202862
• Document Type:
  Journal Article
• Funding:
  BB_/Biotechnology and Biological Sciences Research CouncilUnited Kingdom/
• Volume:
  29
• Issue:
  6
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:9fce80de9d3487bbcf617440bc71fca681e45e9a6aa02ff2cb429f0bec8a6e01
• Download URL:
  https://stacks.cdc.gov/view/cdc/129706/cdc_129706_DS1.pdf
• File Type:
  [PDF - 1.67 MB ]